Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.41 | 80.23 |
PEG Ratio (TTM) | 0.00 | 3.61 |
P/S Ratio (TTM) | 0.12 | 3.14 |
P/B Ratio (TTM) | 1.63 | 14.81 |
P/FCF Ratio (TTM) | -0.24 | 12.60 |
Price to 5YR AVG Earnings Ratio | -3.21 | 49.26 |
Price to 5YR AVG FCF Ratio | -0.15 | 4.12 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -11.89% | 3.17% |
ROE (TTM) | -127.87% | 10.73% |
Net Profit Margin (TTM) | -29.71% | 11.99% |
ROIC 5YR AVG | 2.34% | 8.13% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -131.81% | -797.61% | -69.09% |
Revenue | -0.34% | -1.27% | 4.49% |
Net Income | -131.95% | -1,048.99% | -550.90% |
Cash Flow | 10.80% | 11.94% | 14.77% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.60 | 1.72 |
Quick Ratio (TTM) | 3.60 | 1.24 |
D/E Ratio (TTM) | 24.90 | 5.17 |
Interest Coverage (TTM) | -1.18 | 4.19 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 0.07 | 1.59 |
LTL to 5YR AVG FCF | -2.44 | 11.03 |
Shares Outstanding Growth 5YR AVG | 32.60% | 11.01% |